Replies to post #368971 on Elite Pharmaceuticals Inc (ELTP)

[JamesF1]

You asked if any of your points are wrong. You misspelled Pfizer. Other than that it’s quite accurate… lol. By the way, all of your points are looking in the real view mirror. This is a high risk investment. There is self dealing by the CEO, Elite’s most important partner, Lannett, is at risk of a chapter 11 filing. Those are the biggest risks IMHO. On the upside, the company is currently profitable. There is R&D which has potential to expand the product line and significantly increase sales and profit. Elite has a partnership with an international company, Dexcel. Dexcel, at the moment, is only one product in one country, That partnership has growth potential. Elite’s CEO has connections throughout the pharma industry. More partnerships, or an outright sale of Elite are real possibilities. I will continue to buy ELTP slowly, in small portions. I think the odds favor price appreciation. GLTA